ARCHIVES

Long-term Hormonal Therapy Adds No Additional Benefits

This article is from The Cancer Letter archive.

Vol. 36 No. 9 | September 27, 2013

Download PDF Visit The Full Archive

Related Articles

UCLA, NYU, Ohio States Must Wait Longer For Comprehensive Status

November 28, 1975

In Brief: Bristol To Drop Angiostatin; Protein Fails To Meet Criteria For Development, Firm Says

February 12, 1999

Afinitor and Sutent Approved For Pancreatic Neuroendocrine Tumors

May 27, 2011

Options For Changes, Some Drastic, In Cooperative Groups Suggested By CTEP

April 11, 1986

GYN Group: Open Surgery Would Cost More Lives Than Morcellation

July 25, 2014

Huebner Retires, Named Scientist Emeritus

November 19, 1982